TI
TRVI icon

Trexquant Investment’s Trevi Therapeutics TRVI Stock Holding History

Trexquant Investment’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.52M Buy
+242,537
New +$3.53M 0.03% 795
2025
Q3 		– Sell
-33,962
Closed -$186K – 1920
2025
Q2 		$186K Buy
+33,962
New +$211K ﹤0.01% 1452

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Trexquant Investment's TRVI Position: Q2 2026 in Review

Trexquant Investment opened a new position in Trevi Therapeutics (TRVI) in Q2 2026: 242,537 shares worth $4.52M. The stake represents 0.03% of the portfolio and ranks #795 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in TRVI as recently as Q2 2025.

Trexquant Investment first reported a position in TRVI in Q2 2025 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • Trexquant Investment held 242,537 shares of Trevi Therapeutics worth $4.52M as of Q2 2026.
  • Trevi Therapeutics was a new Trexquant Investment position in Q2 2026.
  • Trevi Therapeutics made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #795 holding.
  • Trexquant Investment first reported a position in Trevi Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.